InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,482.87
(
0.00%
)
US TECH 100
19,364.00
(
0.52%
)
Dow Jones
39,164.06
(
0.00%
)
Brent Oil
85.49
(
0.08%
)
Bitcoin
61,418.45
(
-0.31%
)
Post# of 252412
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ghmm

Send PM Follow Ignore
Followers 50
Posts 6343
Boards Moderated 0
Alias Born 01/22/2006

ghmm

Re: iwfal post# 201298

Tuesday, 05/10/2016 7:58:55 AM

Tuesday, May 10, 2016 7:58:55 AM

Post# of 252412
FGEN:


Did they say how they measured it if not using typical RECIST measurements?



From the SA transcript (Dr. Porter):
http://seekingalpha.com/article/3973391-fibrogens-fgen-ceo-thomas-neff-q1-2016-results-earnings-call-transcript?part=single

Further protocol eligibility for surgical exploration is determined from specific criteria based on the plasma biomarker CA19-9, FTG PEP, tumor response based on CT imaging and the NCC end criteria for resectable or board line resectable tumors.

Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up